sattva neelapu, md, discusses details of the zuma-12 trial presented at ash 2020
Published 3 years ago • 18 plays • Length 3:48Download video MP4
Download video MP3
Similar videos
-
2:13
sattva neelapu | ash 2018 | results from the two-year follow-up of zuma-1
-
1:33
sattva neelapu, md, on real-world experience & clinical studies examining axicabtagene ciloleucel
-
1:16
sattva neelapu: zuma-14
-
3:09
sattva neelapu, md, discusses advancements in the management of car t-cell therapy aes
-
2:25
sattva neelapu, md, shares highlights in the development of car t-cell therapies in lymphoma
-
1:03:44
lc1301 paṭicca samuppāda - dependent origination
-
43:38
anaxgum step-by-step technique - layering on white and pink pmma
-
17:59
defeating adventism 48 – seventh-day adventists phantom sunday law
-
3:17
lori leslie, md, discusses outcomes from the phase ii zuma-5 study presented at ash 2020
-
2:06
zuma-12: axi-cel as first-line therapy in high-risk large b-cell lymphoma
-
3:27
julio chavez, md, ms, shares outcomes from the zuma-5 study presented at ash 2020
-
1:44
comparison of zuma-1 and scholar-1 outcomes
-
3:18
zuma-5: axi-cel for r/r inhl
-
10:22
resectable pancreatic cancer debate: total neoadjuvant vs adjuvant therapy - total neoadjuvant
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
1:03:10
workshop12_apasl oncology 2023 sendai
-
3:02
all about the national pancreas foundation
-
3:31
zuma-1 trial observations
-
47:19
coronavirus lecture with dr. amesh adalja, johns hopkins senior scholar, tepper alumnus
-
8:14
debate 9: optimal adjuvant therapy in pancreatic cancer? - intensified chemotherapy
-
3:34
7. summary and adjourn